DA: Writing original draft, Formal analysis
Research by Rahman A, Paul M
Fasenra had a slight edge on GSKs drug, eliciting a 59% remission rate compared to 56% in the Nucala arm
When pentadecapeptide BPC 157 was given immediately after paracetamol (g-ng range, intraperitoneally or intragastrically), in accordance with a complete absence of convulsions, BPC 157 rats commonly had all alterations markedly less expressed 24 hours after paracetamol, reduced interstitial edema (only mild) and markedly less damaged neurons, without inflammatory reaction
Then, Novo Nordisk worked on a new generation GLP-1 RA, semaglutide, and commercialized it successfully
Patients receive prescriptions for compounded semaglutide or tirzepatide formulated to exact specifications, often at comparable or lower cost